Thomas A. Mitro
2019
In 2019, Thomas A. Mitro earned a total compensation of $2.8M as President and Chief Operating Officer at Aerie Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $103,000 |
|---|---|
| Option Awards | $1,659,848 |
| Salary | $473,800 |
| Stock Awards | $550,348 |
| Other | $5,980 |
| Total | $2,792,976 |
Mitro received $1.7M in option awards, accounting for 59% of the total pay in 2019.
Mitro also received $103K in non-equity incentive plan, $473.8K in salary, $550.3K in stock awards and $6K in other compensation.
Rankings
In 2019, Thomas A. Mitro's compensation ranked 4,380th out of 13,971 executives tracked by ExecPay. In other words, Mitro earned more than 68.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,380 out of 13,971 | 69th |
Division Manufacturing | 1,615 out of 5,701 | 72nd |
Major group Chemicals And Allied Products | 566 out of 2,200 | 74th |
Industry group Drugs | 477 out of 1,886 | 75th |
Industry Biological Products, Except Diagnostic Substances | 104 out of 389 | 73rd |
Source: SEC filing on April 24, 2020.
Mitro's colleagues
We found five more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2019.
2019
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
2019
John LaRocca
Aerie Pharmaceuticals
General Counsel
2019
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2019
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
2019
Casey Kopczynski
Aerie Pharmaceuticals
Chief Scientific Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019